Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety & Efficacy of AYX1 in Total Knee Arthroplasty
NCT02081703Phase 2Completed
- Sponsor
- Adynxx, Inc.
- Start
- May 2014
- Primary completion
- Jun 2015
- Modality
- Antisense DNA, Small Interfering RNA (siRNA), MicroRNA (miRNA)
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of brivoligide in Persistent postsurgical pain (PPSP) (4 arms), sponsored by Adynxx, Inc. Primary endpoints: Pain with walking during 5 meter walk test and Pain with walking during 15 meter walk test. Started May 2014; status: completed.
02
Drugs
brivoligide
03
Conditions
Persistent postsurgical pain (PPSP)
Beyond the preview
Go deeper on NCT02081703.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02081703.